Taken together, the above data show that the apelin/APJ system is capable of promoting glucose utilization through enhancing glucose absorption by adipose tissue and skeletal muscles and modulating insulin resistance and secretion in a dose-dependent manner. This evidence concerns the gene APLN and Insulin resistance.